Preclinical validation of 111In-girentuximab-F(ab')2 as a tracer to image hypoxia related marker CAIX expression in head and neck cancer xenografts (Q47807831)
Jump to navigation
Jump to search
scientific article published on 5 August 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical validation of 111In-girentuximab-F(ab')2 as a tracer to image hypoxia related marker CAIX expression in head and neck cancer xenografts |
scientific article published on 5 August 2017 |
Statements
1 reference
Preclinical validation of 111In-girentuximab-F(ab')2 as a tracer to image hypoxia related marker CAIX expression in head and neck cancer xenografts (English)
1 reference
Otto C Boerman
1 reference
Johan Bussink
1 reference
Bianca A W Hoeben
1 reference
Fokko J Huizing
1 reference
Gerben Franssen
1 reference
Jasper Lok
1 reference
Sandra Heskamp
1 reference
Egbert Oosterwijk
1 reference
5 August 2017
1 reference
124
1 reference
3
1 reference
521-525
1 reference